[ad_1]
Cellink is a young company listed on the list of growth companies of First North, Stockholm Stock Exchange since the autumn of 2016. And the report for the third quarter of the broken fiscal year shows that the company is in a strong and continuous growth.
During the last quarter, sales reached just under 16.4 million Swedish kronor, more than three times more than last year. Unlike last year, the company also shows some profit – the pre-tax profit is just over 0.6 million.
World Growth
"Demand for Cellink's technological platform continued to increase in the third quarter" Gatenholm, co-founder and most important owner of the company
He notes that several research projects were published in which the company's 3D organ and tissue printer was used, including the bioprinting journal. In addition, Newcastle researchers have shown that Cellink's technology can be used to print human corneas in less than ten minutes.
During the last quarter, the biotech company also launched a bioscientist for education called Cellink Go. The number of employees is steadily increasing and now stands at just over 50
The stock reacted positively to the quarterly report and the stock rose more than four percent on Wednesday morning.
Source link
